This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: University of Central Florida Research Foundation Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Rania Bassiouni: Innovator in Cancer Treatment
Introduction
Rania Bassiouni is a prominent inventor based in Orlando, FL (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 2 patents, her work focuses on the development of compositions that utilize a CT20 peptide to target specific cancer types.
Latest Patents
Rania Bassiouni's latest patents include a method and compositions comprising a CT20 peptide. These patents disclose compositions that utilize the CT20 peptide and outline methods for using these compositions to treat cancers that express chaperonin containing TCP (CCT). This innovative approach has the potential to advance cancer treatment significantly.
Career Highlights
Rania Bassiouni is affiliated with the University of Central Florida Research Foundation Inc., where she conducts her research. Her work is characterized by a commitment to developing effective treatments for cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Some of Rania's notable coworkers include Annette Khaled and Jesus Manuel Perez. Their collaborative efforts contribute to the advancement of research in cancer treatment and the development of innovative solutions.
Conclusion
Rania Bassiouni is a trailblazer in the field of cancer research, with her patented methods offering promising avenues for treatment. Her contributions reflect a deep commitment to innovation and the pursuit of effective therapies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile